GVR Report cover Facial Injectable Market Size, Share & Trends Report

Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), By Application (Aesthetic, Therapeutic), By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Aug, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-1-68038-849-7
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 172

Report Overview

The global facial injectable market size was valued at USD 13.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.8% from 2021 to 2028. A growing focus on physical appearance among consumers has led to an increased demand for facial injectables in recent years. The ongoing COVID-19 pandemic has increased the time spent on video calls. Known as the ‘Zoom Boom’, several adults are becoming more aware of their appearance. This has increased demand for cosmetic surgeries, with Botox being one of the most popular products preferred. Patients are also opting for cosmetic surgeries owing to ease of recovery while staying at home. Thus, the market has witnessed a spike during the pandemic.

U.S. facial injectable market size, by product, 2018 - 2028 (USD Billion)

Minimally invasive surgeries are rapidly replacing invasive surgeries. For instance, according to the American Society of Plastic Surgeons (ASPS), in the U.S, nearly 17.7 million minimally invasive and surgical cosmetic products were performed in 2018, out of which nearly 15.9 million products were minimally invasive. Thus, the increasing adoption of minimally invasive surgeries, coupled with the availability of a wide range of such treatment options, is driving the market for facial injectables.

According to the International Society of Aesthetic Plastic Surgery (ISAPS), the U.S. was ranked 1st in terms of non-surgical products performed at a global level. Of these, injectables such as botulinum toxin and hyaluronic acid were among the most popular products performed. The country is backed by advanced treatment options and has the highest number of surgeons at a global level, with over 7,000 plastic surgeons as of 2019. These factors support market growth.

COVID19 impact: 51% increase in demand is expected in the coming years

Pandemic Impact

Post COVID Outlook

The imposition of national lockdowns and subsequent closure of clinics has negatively impacted aesthetic practices. According to a survey by Hamilton Fraser, in 2020, nearly 99.78% of participants reported that their practice was affected by the COVID-19 pandemic, with around 80.51% of aesthetic practitioners reporting the closure of clinics, around 67.28% reporting reduction in revenue while about 63.31% reporting reduction in inquiries.

Post covid, increasing focus on digital consultations is expected to be one of the priorities of practitioners to ensure patient engagement.

AbbVie reported a loss in Botox sales in Q2 of 2020 due to the COVID-19 pandemic. AbbVie Inc acquired Allergan in May 2020.

According to a study conducted by Cynosure, nearly 62% of the practitioners were confident about their business revenue returning to pre-Covid level within 12 months of the lifting of impositions


Incidents of adverse reactions to the Moderna COVID-19 vaccine in patients with dermal fillers have created fear amongst patients.


In June 2020, Allergan Aesthetics, a subsidiary of AbbVie Inc. (U.S.), received FDA approval of JUVÉDERM VOLUMA XC for the augmentation of the chin region in adults over the age of 21. Apart from this, in 2019, FDA approved, Jeuveau, which is similar to Botox, however, available at a lower cost compared to Botox. The product is found to be effective in reducing wrinkles.

Product Insights

The botulinum toxin Type A segment dominated the facial injectable market and accounted for the largest revenue share of 55.2% in 2020. Middle-aged women are increasingly opting for fillers and injectables including the popular, Botox to reverse the signs of aging. The Hyaluronic Acid (HA) segment is projected to witness the fastest-growing at a CAGR of 9.4% during the forecast period. It is known for its ability to store moisture in the skin, thus making the skin look healthier. HA has a moisture-binding characteristic that helps enhance and maintain the vital moisture responsible for the plumpness of the facial skin.

Application Insights

The aesthetics segment is expected to dominate the market and accounted for the largest revenue share of 70.5% in 2020. This growth is owing to the increasing use of facial injectables for aesthetics procedures such as facial lines, wrinkles on the face, and lip lines, to name a few.

Global facial injectable market share, by application, 2020 (%)

The growing interest in physical appearance along with an increase in disposable income among the middle-class population in developing countries such as India is expected to boost demand for facial injectable for aesthetic purposes in the coming years. The therapeutic segment is expected to register a double-digit CAGR over the forecast period. This is attributed to increasing applications of facial injectables in the treatment of blepharospasm, strabismus or crossed eyes, Meige's syndrome, Oromandibular Dystonia (OMD), Hemifacial Spasms (HFS) and focal hyperhidrosis.

Regional Insights

North America dominated the market and accounted for the largest revenue share of more than 41.0% in 2020. This growth is owing to large geriatric population in the U.S. and Canada is anticipated to propel the demand for facial injectables over the forecast period.

According to the American Society of Plastic Surgeons (ASPS), the growth in rates of cosmetic surgery products from the year 2000 to 2018 was compared.  It was observed that the use of Botox injections increased by 845%. Thus, North America is expected to be a key revenue generator for facial injectables in the coming years.

In Asia Pacific, the market is projected to witness the highest CAGR of 10.0% during the forecast period. The region is backed by countries such as India, Australia, and South Korea. Growing focus towards the physical appearance in these developing countries is expected to play a key role in the demand for facial injectable treatment. India is projected to be the fastest-growing during the forecast period.

Key Companies & Market Share Insights

The key players are focusing on growth strategies, such as enhancements in the existing technologies, geographical expansion, product launches, and product approvals. Recently, in 2019, one of the key players, Allergan, had launched a TV ad campaign for its brand, Botox Cosmetics for millennials. According to the American Academy of Facial Plastic and Reconstructive Surgery, in the past five years, Botox injections have increased by 22% among 22- to 37-year-olds, focusing on which the product is being launched by the company. Some of the prominent players in the facial injectable market include:

  • Allergan

  • Hologic (cynosure)

  • Johnson & Johnson

  • Galderma

  • Lumenis

  • Solta Medical

  • Syneron Candela

  • Alma Laser

Facial Injectable Market Report Scope

Report Attribute


Market size value in 2021

USD 15.3 billion

Revenue forecast in 2028

USD 27.7 billion

Growth Rate

CAGR of 8.8% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, application, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Switzerland; Netherland; Belgium;  Japan; China; India; Australia; South Korea; Thailand; Malaysia; Singapore; Indonesia; Philippines; Brazil; Mexico; Argentina; Colombia; Chile; South Africa; Saudi Arabia; UAE; Israel; Turkey

Key companies profiled

Allergan; Hologic (cynosure); Johnson & Johnson; Galderma; Lumenis; Solta Medical; Syneron Candela; Alma Laser

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global facial injectable market report on the basis of product, application, and region:

  • Product Outlook (Volume, Number of Procedures; Revenue, USD Million, 2016 - 2028)

    • Collagen

    • Hyaluronic Acid (HA)

    • Botulinum Toxin Type A

    • Calcium Hydroxylapatite (CaHA)

    • Polymer Fillers

      • Polymethylmethacrylate beads (PMMA Microspheres)

      • Poly-L-Lactic Acid (PLLA)

  • Application Outlook (Revenue, USD Million, 2016 - 2028)

    • Aesthetics

    • Therapeutics 

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Switzerland

      • Netherland

      • Belgium

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • Thailand

      • South Korea

      • Malaysia

      • Singapore

      • Indonesia

      • Philippines

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

      • Chile

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Israel

      • Turkey

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.